EXCLUSIVE RESEARCH, DEVELOPMENT, LICENSE AND MANUFACTURING AND SUPPLY AGREEMENT BY AND AMONG NEKTAR THERAPEUTICS AL, CORPORATION AND BAXTER HEALTHCARE SA AND BAXTER HEALTHCARE CORPORATION DATED SEPTEMBER 26, 2005Exclusive Research, Development, License and Manufacturing and Supply Agreement • March 6th, 2009 • Nektar Therapeutics • Pharmaceutical preparations • California
This Agreement (this “AGREEMENT”) is made and entered into as of September 26, 2005 (the “EFFECTIVE DATE”) by and among Nektar Therapeutics AL, Corporation, an Alabama corporation, having its principal place of business at 490 Discovery Drive, Huntsville, AL 35806 (“NEKTAR AL”), Baxter Healthcare SA (“BHSA”), a corporation organized and existing under the laws of Switzerland, and Baxter Healthcare Corporation (“BHC”), a Delaware corporation, having its principal place of business at One Baxter Parkway, Deerfield, Illinois 60015 (BHSA and BHC collectively referred to as “BAXTER”). NEKTAR AL and BAXTER may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
Nektar Therapeutics 201 Industrial Road San Carlos, California 94070Employment Agreement • March 6th, 2009 • Nektar Therapeutics • Pharmaceutical preparations
This letter agreement supersedes the offer letter agreement you entered into with Nektar Therapeutics (“Nektar” or the “Company”) on January 5, 2007 and any other understandings and agreements, written or oral, between you and the Company with respect to the subject matter herein and is made effective as of the date set forth above. Capitalized terms used herein and not defined shall have the meanings ascribed to them in the Company’s Change of Control Severance Benefit Plan, as it may be amended from time to time (the “COC Plan” a copy of which is included herein).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 6th, 2009 • Nektar Therapeutics • Pharmaceutical preparations
This EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) dated as of December 31, 2008 is entered into by and between Novartis Pharma AG, a corporation organized under the laws of Switzerland, having a place of business at Lichtstrasse 35, 4056, Basel, Switzerland (“Licensor”), and Nektar Therapeutics, a Delaware corporation, having a place of business at 201 Industrial Road, San Carlos, CA 94070 (the “Company”). Licensor and Company are each referred to herein as a “Party”, and collectively, as the “Parties”.
Nektar Therapeutics 201 Industrial Road San Carlos, California 94070Offer Letter Agreement • March 6th, 2009 • Nektar Therapeutics • Pharmaceutical preparations • California
Nektar Therapeutics 201 Industrial Road San Carlos, California 94070Offer Letter Agreement • March 6th, 2009 • Nektar Therapeutics • Pharmaceutical preparations
Nektar Therapeutics 201 Industrial Road San Carlos, California 94070Offer Letter Agreement • March 6th, 2009 • Nektar Therapeutics • Pharmaceutical preparations
